专家观点:POET II试验显示感染性心内膜炎响应指导型抗生素短疗程需权衡复发风险
Duration of antibiotic treatment for infective endocarditis: should we move towards tailored therapy?
La Timone医院心脏科专家Philip和Habib在Nature Reviews Cardiology撰文指出,POET II试验显示在临床稳定的感染性心内膜炎患者中停止抗生素治疗缩短了疗程且未增加死亡或手术风险,但使心内膜炎或菌血症复发率增加至三倍。该响应指导型策略标志着向POET试验口服抗生素转换范式之外的转变,其安全性取决于严格的患者选择和密切的多学科随访。
原文基于POET II试验数据,讨论了响应指导型抗生素短疗程在降低复发风险方面的局限性。
- News & Views
- Published: 15 October 2026
Nature Reviews Cardiology (2026) Cite this article
The POET II trial reports that stopping antibiotic treatment in patients with endocarditis once they are clinically stable shortens the treatment duration without excess risk of death or surgery, but triples the rates of relapse of endocarditis or bacteraemia. This response-guided strategy marks a genuine shift beyond the oral-antibiotic-switch paradigm from the POET trial, and the safety of the approach will depend on rigorous patient selection and close multidisciplinary follow-up.
This is a preview of subscription content, access via your institution
Access options
Access through your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
27,99 € / 30 days
cancel any time
Subscription info for Chinese customers
We have a dedicated website for our Chinese customers. Please go to naturechina.com to subscribe to this journal.
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
References
Habib, G. et al. 2015 ESC guidelines for the management of infective endocarditis. Eur. Heart J. 36, 3075–3128 (2015).
Iversen, K. et al. Partial oral versus intravenous antibiotic treatment of endocarditis. N. Engl. J. Med. 380, 415–424 (2019).
Delgado, V. et al. 2023 ESC guidelines for the management of endocarditis. Eur. Heart J. 44, 3948–4042 (2023).
Bundgaard, H. et al. Response-tailored or standard-duration antibiotic treatment for infective endocarditis. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2607887 (2026).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03851575 (2019).
Pries-Heje, M. M. et al. Clinical implementation of partial oral treatment in infective endocarditis: the Danish POETry study. Eur. Heart J. 44, 5095–5106 (2023).
Østergaard, L. et al. Accelerated treatment of endocarditis: the POET II trial: rationale and design of a randomized controlled trial. Am. Heart J. 227, 40–46 (2020).
Chu, V. H. et al. Repeat infective endocarditis: differentiating relapse from reinfection. Clin. Infect. Dis. 41, 406–409 (2005).
Østergaard, L. et al. Temporal changes, patient characteristics, and mortality, according to microbiological cause of infective endocarditis: a nationwide study. J. Am. Heart Assoc. 11, e025801 (2022).
Author information
Authors and Affiliations
Department of Cardiology, La Timone Hospital, APHM, Marseille, France
Mary Philip & Gilbert Habib
Authors
- Mary Philip
- Gilbert Habib
Corresponding author
Correspondence to Gilbert Habib.
Ethics declarations
Competing interests
The authors declare no competing interests.
About this article
Cite this article
Philip, M., Habib, G. Duration of antibiotic treatment for infective endocarditis: should we move towards tailored therapy?. Nat Rev Cardiol (2026). https://doi.org/10.1038/s41569-026-01360-1
Published: 15 October 2026
Version of record: 15 October 2026
DOI: https://doi.org/10.1038/s41569-026-01360-1
来源:Nature 健康护理主题 · nature.com